HCM
AUXL

Highbridge Capital Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Highbridge Capital Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,883
Closed -$270K – 1553
2013
Q3 		$270K Sell
14,883
-114,030
-88% -$2.06M ﹤0.01% 1085
2013
Q2 		$2.14M Buy
+128,913
New +$2.06M 0.02% 473

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's AUXL Position: Q4 2013 in Review

Highbridge Capital Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2013, closing a stake of 14,883 shares — an estimated $270K sold.

Highbridge Capital Management first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $2.14M in Q2 2013. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

  • Highbridge Capital Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Highbridge Capital Management sold 14,883 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2013, an estimated $270K.
  • Highbridge Capital Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Highbridge Capital Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $2.14M in Q2 2013.
  • 147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.